Adecto Pharmaceuticals
Company Details
Status: Private
Employees: 1-10
Location:
Boston, Massachusetts, United States
Type:
sample
Technology:
sample
sample
sample
About: Adecto is a pre-clinical stage, cancer therapeutics company, developing the first targeted therapy against ADAM8-expressing cancers and a companion diagnostic to identify patients who can benefit from it. ADAM8 is a critical driver of the growth and spread of many aggressive tumors, including those of the breast, stomach, colon, lungs, liver and pancreas, and is associated with poor patient survival. Adecto’s current focus is on breast cancer with a plan to expand to other oncology indications in the future.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!

Adecto Pharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.